Skip to main content

Nexium: MDL No. 2757

Nexium: MDL No. 2757

Nexium: MDL No. 2757

Introduction

Nexium: MDL No. 2757; in re: Proton-pump inhibitor Products liability litigation, created in August 2017, presided by Judge Claire C. Cecchi, in the U.S. District of New Jersey. Other defendants include makers of Prilosec, Prevacid, and others. As of January 2018 status report, there are 469 lawsuits pending in the federal MDL, which involve 503 plaintiffs. In addition, there are about another 227 related lawsuits pending in state courts, with 127 pending in the Delaware Superior Court.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Lawyers to Meet Nov. 5 for Talcum Powder Trial Prep

Categories: Talcum

As the first federal talcum powder bellwether trial approaches, both plaintiffs and defendants have finalized their legal teams and are preparing for a key pretrial conference scheduled for early November.

The upcoming proceedings mark a…

2025 Update: What to Know About PPI Lawsuit Settlements & Payout Dates

Categories: Settlements

Last updated on Oct 27, 2025.

The mass tort litigation involving proton pump inhibitor (PPI) drugs — such as Nexium, Prilosec, Prevacid and Protonix — is entering a pivotal phase in

New Front Emerges in Fight Against Synthetic Opioids

Categories: Opioids

The U.S. opioid crisis has already claimed hundreds of thousands of lives, with fentanyl standing out as one of the deadliest substances. Now the leading cause of death among Americans aged 18 to 44, fentanyl has become synonymous with overdose…

⏳ Save 80+ Hours Monthly — Try Medical Records Review for FREE!                     
💼 Delivered in 7 Days. No AI. No Contracts.
Handled by Certified Doctors — 100% Compliant.

Only 5 Free Slot remain — Offer Ends Soon!